Exhale

The official blog of the Lung Institute.

Medical Innovation Past and Present

090115_FB-Blog_17-31

Medical Innovation Past and Present

Penicillin:

Sir Alexander Fleming, a Scottish researcher, is credited with the discovery of penicillin in 1928. He was experimenting with the influenza virus in the laboratory of the Inoculation Department at St. Mary’s Hospital in London.

Fleming returned from a two-week vacation to find mold growing on an accidentally contaminated staphylococcus culture plate. Upon examination, Fleming noticed that the mold culture prevented the growth of staphylococci bacteria.

Penicillin made a difference during the first half of the 20th century. The first patient was successfully treated for streptococcal septicemia in the United States in 1942, putting any misgivings about the treatment to rest after more than a decade of development. With the onset of World War II, supply was limited and demand was high for penicillin.

 

Organ transplantation:

The ability to transplant organs is one of the greatest medical innovations. Though it affords people a new lease on life, it wasn’t immediately accepted by traditional society. Job van Meekeren, a Dutch physician, recorded the first documented successful bone transplant, using bone from a dog’s skull to fix a defect in a Russian soldier’s skull. The Russian Orthodox Church condemned the transplant as unnatural. It wasn’t until 1990 that the Roman Catholic Church openly supported organ transplant as, according to then-Pope John Paul II, the ultimate expression of love and charity towards humanity.

Some day, organs and other tissue grown from our own stem cells may be in wide use. But in the meantime, whether or not to become a donor remains one of the most important choices we will ever make as individuals.

 

Cell therapy:

Twenty-four million U.S. adults have evidence of impaired lung function, indicating a probable COPD diagnosis. The Centers for Disease Control and Prevention (CDC) reports that 12.7 million U.S. adults were estimated to have COPD in 2011. These numbers have only grown.

Once thought of as being a “man’s disease,” the prevalence of COPD among women has grown significantly. In 2011, women surpassed men for the tenth consecutive year in having a higher rate of chronic bronchitis diagnosis. The numbers speak for themselves with 3.3 million U.S. men diagnosed compared to 6.8 million women.

 

About Lung Institute

At Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life.  Our physicians have gained worldwide recognition for the successful application of revolutionary, minimally invasive cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety, comfort, and quality of care.

If you or a loved one has COPD or other lung disease and want to learn more about treatment options, contact us or call (800) 729-3065.

 

 

Your Comment

Your email address will not be published.



* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.